Delivery Order SPE2DB25D3201-SPE2DB25FNTSH

Award Date 6/5/25
Potential Completion Date 6/6/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,997.18 firm-fixed-price delivery order is for the supply of MICAFUNGIN 50 MG VIALS, a pharmaceutical product. The contract has a period of performance extending until June 10, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,304.49 firm-fixed-price contract is for the delivery of 4565862435 MICAFUNGIN 100 MG VIALS. This award is a delivery order under the DLA Troop Support Medical Indefinite Delivery Contract, a $999,999,999 vehicle that provides a wide range of medical commodities to support military treatment programs and facilities worldwide....
This federal contract award is for the delivery of MICAFUNGIN 50 MG VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $4,087.19, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of June 9, 2025. There is no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,775.46 firm fixed-price delivery order is for the supply of 100 mg MICAFUNGIN vials. The contract has an ultimate completion date of June 6, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,059.86 Firm Fixed Price Delivery Order covers the supply of 4,565,095,704 units of Caspofungin Acetate 50 MG Vials, with an ultimate completion date of July 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,250,777 units of Mitomycin 5 mg vials, a chemotherapy medication. The contract has a firm fixed price of $2,751.36 and a completion date of May 15, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,818.90, is for the delivery of Mitomycin 5 mg vials, a specialty cancer medication. The contract is a firm fixed-price, delivery order type with a completion date of May 30, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,628.95, is for the delivery of MITOMYCIN 20 MG VIALS, a specialty pharmaceutical product. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract covers the supply of a variety of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The specific order is...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00. The delivery order, worth $16,554.44, is for the supply of various pharmaceutical and medical products, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and antibiotics, as well as specialized medical supplies. The contract is...
  • SPE2DB25D3201
    Indefinite Delivery Contract
  • SPE2DB25D3201-SPE2DB25FNTSH
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for the supply of 100 mg vials of the antifungal medication Micafungin. The contract has a firm-fixed price of $1,721.36 and a period of performance through June 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The contract is not designated as a set-aside.

Generated 9/4/25, 9:49 AM